Quick Takeaways
- Timothy Coughlin has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,205,153.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Timothy Coughlin
- Location
- Solana Beach, CA
- Summary
- The estimated net worth of Timothy Coughlin is at least $2,205,153 dollars as of 04 Nov 2025. Timothy Coughlin is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $1.94M. Timothy Coughlin is the Director of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $109.2K. Timothy Coughlin is the Director of aTYR PHARMA INC and owns shares of aTYR PHARMA INC (ATYR) stock worth about $98K. Timothy Coughlin is the Director of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $53.6K.
- Signature
- /s/ Elizabeth E. Reed, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Timothy Coughlin and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Travere Therapeutics, Inc. ($1,944,353).
- Past-year value change for that position: -$630,601.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Timothy Coughlin
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Director | $1,944,353 | -$630,601 | -24% | 31 Oct 2025 |
| FATE | FATE THERAPEUTICS INC | Director | $109,200 | 07 Jun 2024 | ||
| ATYR | aTYR PHARMA INC | Director | $98,000 | 01 May 2025 | ||
| ADCT | ADC Therapeutics SA | Director | $53,600 | 03 Jun 2025 |
Insider Transactions Reported by Timothy Coughlin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.